Skip to main content
Premium Trial:

Request an Annual Quote

AnPac Bio-Medical Nabs $7M Equity Investment for Cancer Early Detection Platform

NEW YORK – AnPac Bio-Medical Science said on Thursday that it has signed an agreement with Keystone Capital Partners for a preferred stock investment for an aggregate purchase price of $7 million.

The Shanghai-based firm will use the funding to advance its Cancer Differentiation Analysis (CDA) technology to provide cost-effective, early detection screening and testing of 26 cancers.

According to a prospectus summary filed with the US Securities and Exchange Commission, AnPac will offer 700,000 shares at a price of $10.00 per share to Keystone.

AnPac also noted that the investment will provide it with additional access to growth capital to expand its operations in China and continue commercialization efforts in the US.

The prospectus summary also noted that AnPac's proprietary CDA device uses an integrated sensor system to detect biophysical signals in blood samples. After collecting data on the signals, the firm uses its CDA technology and proprietary algorithm to measure and analyze the signals at multiple biological levels, including, protein, cellular, and molecular signals using multiple parameters.

The firm also said it offers biochemical, immunological, and genomic tests out of its CLIA-certified, CAP-accredited labs in the US and China.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.